title: Oxybutynin and cognitive dysfunction.
authors.affiliation: Department of Geriatric Medicine, Royal Liverpool University Hospital.
authors.forename: C A
authors.initials: CA
authors.lastname: Donnellan
authors.forename: L
authors.initials: L
authors.lastname: Fook
authors.forename: P
authors.initials: P
authors.lastname: McDonald
authors.forename: J R
authors.initials: JR
authors.lastname: Playfer
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D018680:Cholinergic Antagonists / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000139:chemically induced*; D003221:Confusion / Q000139:chemically induced; D006801:Humans; D008297:Male; D008333:Mandelic Acids / Q000009:adverse effects*; D010300:Parkinson Disease / Q000188:drug therapy
chemical_list: D018680:Cholinergic Antagonists; D008333:Mandelic Acids; C005419:oxybutynin